Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 4
Submit an article Journal homepage
63
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Breast Cancer Resistance Protein (BCRP) in Acute Leukaemia

Sabine LA Plasschaert Division of Paediatric Oncology and Haematology, University Hospital Groningen, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The NetherlandsCorrespondence[email protected]
,
Dorina M Van Der Kolk Division of Haematology, University Hospital Groningen, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
,
Eveline SJM De Bont Division of Medical Oncology, University Hospital Groningen, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
,
Edo Vellenga Division of Paediatric Oncology and Haematology, University Hospital Groningen, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
,
Willem A Kamps Division of Haematology, University Hospital Groningen, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
&
Elisabeth GE De Vries Division of Medical Oncology, University Hospital Groningen, Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands
Pages 649-654 | Received 13 Jun 2003, Published online: 03 Aug 2009

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kohji Noguchi, Kazuhiro Katayama & Yoshikazu Sugimoto. (2014) Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics. Pharmacogenomics and Personalized Medicine 7, pages 53-64.
Read now

Articles from other publishers (28)

Melanie Zechner, Claudia A. Castro Jaramillo, Nadine S. Zubler, Marco F. Taddio, Linjing Mu, Karl-Heinz Altmann & Stefanie D. Krämer. (2023) In Vitro and In Vivo Evaluation of ABCG2 (BCRP) Inhibitors Derived from Ko143 . Journal of Medicinal Chemistry 66:10, pages 6782-6797.
Crossref
Robert W. Robey, Sabrina Lusvarghi, Cindy H. Chau, Agnes Basseville, William D. Figg, Suresh V. Ambudkar & Susan E. Bates. 2022. Drug Transporters. Drug Transporters 235 256 .
László Homolya. (2021) Medically Important Alterations in Transport Function and Trafficking of ABCG2. International Journal of Molecular Sciences 22:6, pages 2786.
Crossref
Adrian C. Jaramillo, Jacqueline Cloos, Clara Lemos, Ronald W. Stam, Gertjan J.L. Kaspers, Gerrit Jansen & Godefridus J. Peters. (2019) Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation. Leukemia Research 79, pages 45-51.
Crossref
Noelle Frey, Jun Ho Jang, Jeff Szer, Árpád Illés, Hee-Je Kim, Ron Ram, Beng H Chong, Jacob M Rowe, Elena Borisenkova, Jane Liesveld, Eric S Winer, Azzeddine Cherfi, Vassilios Aslanis, Farhat Ghaznawi & Stephen Strickland. (2019) Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study. The Lancet Haematology 6:3, pages e122-e131.
Crossref
Romone M. Fancy, Lingyun Wang, Qinghua Zeng, Hong Wang, Tong Zhou, Donald J. Buchsbaum & Yuhua Song. (2016) Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells. Journal of Biological Chemistry 291:24, pages 12862-12870.
Crossref
D. Imrichova, L. Messingerova, M. Seres, H. Kavcova, L. Pavlikova, M. Coculova, A. Breier & Z. Sulova. (2015) Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure. European Journal of Pharmaceutical Sciences 77, pages 29-39.
Crossref
Branimir I. Sikic. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer 651 660.e4 .
Xiao-kun Wang, Jie-hua He, Jing-hong Xu, Sheng Ye, Fang Wang, Hui Zhang, Zhen-cong Huang, Kenneth Kin Wah To & Li-wu Fu. (2014) Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells. Cancer Research 74:16, pages 4431-4445.
Crossref
Agnes Basseville, Robert W. Robey, Julian C. Bahr & Susan E. Bates. 2014. Drug Transporters. Drug Transporters 187 221 .
Eric Schafer & Donald Small. 2010. Leukemias: Principles and Practice of Therapy. Leukemias: Principles and Practice of Therapy 56 76 .
Douglas D. Ross & Takeo Nakanishi. 2010. Multi-Drug Resistance in Cancer. Multi-Drug Resistance in Cancer 251 290 .
Kohji Noguchi, Kazuhiro Katayama, Junko Mitsuhashi & Yoshikazu Sugimoto. (2009) Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy. Advanced Drug Delivery Reviews 61:1, pages 26-33.
Crossref
Angelika M. Burger. 2009. Stem Cells and Cancer. Stem Cells and Cancer 263 273 .
Robert W. Robey, Suneet Shukla, Elizabeth M. Finley, Robert K. Oldham, Daryl Barnett, Suresh V. Ambudkar, Tito Fojo & Susan E. Bates. (2008) Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®. Biochemical Pharmacology 75:6, pages 1302-1312.
Crossref
Branimir I. Sikic. 2008. The Molecular Basis of Cancer. The Molecular Basis of Cancer 583 592 .
Curtis J. Henrich, Robert W. Robey, Heidi R. Bokesch, Susan E. Bates, Suneet Shukla, Suresh V. Ambudkar, Michael Dean & James B. McMahon. (2007) New inhibitors of ABCG2 identified by high-throughput screening. Molecular Cancer Therapeutics 6:12, pages 3271-3278.
Crossref
Saranya Chumsri, William Matsui & Angelika M. Burger. (2007) Therapeutic Implications of Leukemic Stem Cell Pathways. Clinical Cancer Research 13:22, pages 6549-6554.
Crossref
Yan Li, Kazuhiro Tanaka, Xu Li, Takamitsu Okada, Tomoyuki Nakamura, Minoru Takasaki, Shunsaku Yamamoto, Yoshinao Oda, Masazumi Tsuneyoshi & Yukihide Iwamoto. (2007) Cyclin‐dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug‐resistant osteosarcoma and Ewing's family tumor cells. International Journal of Cancer 121:6, pages 1212-1218.
Crossref
Robert W. Robey, Orsolya Polgar, John Deeken, Kin Wah To & Susan E. Bates. (2007) ABCG2: determining its relevance in clinical drug resistance. Cancer and Metastasis Reviews 26:1, pages 39-57.
Crossref
Krzysztof Mrózek, Hartmut Döhner & Clara D Bloomfield. (2007) Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances. Current Opinion in Hematology 14:2, pages 106-114.
Crossref
M. Silberberg, A. Gil-Izquierdo, L. Combaret, C. Remesy, A. Scalbert & C. Morand. (2006) Flavanone metabolism in healthy and tumor-bearing rats. Biomedicine & Pharmacotherapy 60:9, pages 529-535.
Crossref
Walter Brand, Maaike E. Schutte, Gary Williamson, Jelmer J. van Zanden, Nicole H.P. Cnubben, John P. Groten, Peter J. van Bladeren & Ivonne M.C.M. Rietjens. (2006) Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomedicine & Pharmacotherapy 60:9, pages 508-519.
Crossref
Jozef Hatok, Peter Račay, Jan Hudeček & Dušan Dobrota. (2006) Genes of multidrug resistance in haematological malignancies. Biologia 61:3, pages 247-256.
Crossref
Jean Boutonnat, Anne-Marie Faussat, Jean-Pierre Marie, Jérôme Bignon, Johanna Wdzieczak-Bakala, Magali Barbier, Josiane Thierry, Xavier Ronot & Pierre-Emmanuel Colle. (2005) Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide – AcSDKP. BMC Cancer 5:1.
Crossref
Qingcheng Mao. (2005) Role of the breast cancer resistance protein (ABCG2) in drug transport. The AAPS Journal 7:1, pages E118-E133.
Crossref
Ute Galm, Martin H. Hager, Steven G. Van Lanen, Jianhua Ju, Jon S. Thorson & Ben Shen. (2005) Antitumor Antibiotics:  Bleomycin, Enediynes, and Mitomycin. Chemical Reviews 105:2, pages 739-758.
Crossref
Noboru Okamura, Toshiyuki Sakaeda & Katsuhiko Okumura. (2004) Pharmacogenomics of MDR and MRP subfamilies. Personalized Medicine 1:1, pages 85-104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.